Physician profile
Allen D Hamdan
NPI 1164489217
$18,860.46
in general payments reported to CMS, 2019-2025
11 companies · $7,999 in 2025
The $7,999 reported for 2025 was more than what 88% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $457 · 2021: $875 · 2022: $1,831 · 2023: $187 · 2024: $7,512 · 2025: $7,999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,197 · Consulting Fee: $6,600 · Food and Beverage: $1,900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,196.80 |
| Consulting Fee | $6,600.00 |
| Food and Beverage | $1,900.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $7,974.46 | 2025 | |
| Transmedics, INC. | $6,592.14 | 2024 | Organ Care System |
| Silk Road Medical, INC. | $1,775.09 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Abbott Laboratories | $1,200.00 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $906.41 | 2019-2024 | Gore Excluder Aaa Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Cook Medical LLC | $207.52 | 2019-2022 | |
| Endologix LLC | $127.81 | 2024 | |
| Averitas Pharma INC. | $52.76 | 2024 | Qutenza |
| Tactile Systems Technology INC | $24.27 | 2025 | Nimbl, Flexitouch Plus |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Hamdan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.